• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Injectable Drug Delivery Devices Market

    ID: MRFR/MED/0704-CR
    164 Pages
    Rahul Gotadki
    August 2019

    Injectable drug delivery Market Research Report Information by Devices (Conventional Injection Devices, Self-Injection Devices), By Therapeutic Application (Autoimmune Diseases, Hormonal Disorders and Cancer) By Usage Pattern (Curative pattern, Immunization), By Site of Delivery (Intramuscular, Subcutaneous, Intra Dermal), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Injectable Drug Delivery Devices Market Research Report - Global Forecast To 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    Injectable Drug Delivery Devices Market Summary

    As per Market Research Future Analysis, the Global Injectable Drug Delivery Market was valued at USD 114.44 Billion in 2023 and is projected to reach USD 229.21 Billion by 2032, growing at a CAGR of 7.21% from 2024 to 2032. The market is driven by the increasing demand for user-friendly and efficient medication delivery systems, particularly self-injection devices. The rise in chronic diseases and the need for innovative drug delivery methods are further propelling market growth. Key players are focusing on R&D and strategic partnerships to enhance their product offerings.

    Key Market Trends & Highlights

    The Injectable Drug Delivery Market is witnessing significant growth due to various factors.

    • Market Size in 2023: USD 114.44 Billion; projected to reach USD 229.21 Billion by 2032.
    • CAGR during 2024-2032: 7.21%; driven by demand for efficient drug delivery systems.
    • Self-injection devices held the majority market share in 2022; fastest-growing segment.
    • Immunization segment dominated revenue in 2022; expected to grow rapidly due to pandemic response.

    Market Size & Forecast

    2023 Market Size USD 114.44 Billion
    2032 Market Size USD 229.21 Billion
    CAGR (2024-2032) 7.21%

    Major Players

    Eisai Co. Ltd, Antares Pharma, AstraZeneca, Becton, Dickinson and Company, Eli Lilly and Company, Hoffmann-La Roche AG, Johnson & Johnson Services Inc., Mylan N.V., Novartis AG.

    Injectable Drug Delivery Devices Market Trends

    Risk of infectious diseases to propel market growth

    The conventional vial-and-syringe drug administration method has a significant risk of infections and is prone to dosing and handling errors. Alternatively, as they are a secure and highly efficient method of drug delivery to the body, this can be reduced by utilizing pre-filled syringes and reusable glass syringes. Growing patient knowledge and enthusiasm for an easy-to-use, minimally invasive method of injectable drug delivery is what's driving the market's expansion globally. The development of low-cost systems due to their efficiency, precise delivery, and simplicity is another factor boosting the market for injectable medication delivery.

    Additionally, it is projected that the booming innovations for creating unique drug delivery methods and the quick development of healthcare infrastructure would increase product sales, assisting in the market's growth throughout the forecast period. Thus, this factor is driving the market CAGR.

    Technological advancements have significantly impacted the drug distribution sector. For instance, Lexaria Bioscience announced in March 2020 that it would begin researching its Dehydra Tech drug delivery system to combat COVID-19. The upgrade of OXYCAPT, a multilayer plastic vial and syringe that enables numerous qualities, such as an exceptional oxygen barrier, UV barrier, and others, was also announced by Mitsubishi in October 2019. Therefore, it is anticipated that increasing R&D spending and launching cutting-edge products by competitors will foster the market's expansion.

    During the forecast period, there will be increased usage of wearable, pen-injector, and needle-free injectors for managing infectious and chronic diseases. Numerous pharmaceutical businesses have started updating their offers by reviewing their packaging and sterilizing providers as a result of COVID-19's impact on public awareness of hygiene and safety. The goal of the combination between Catalent and Bristol-Myers Squibb is to provide sterile product manufacturing and packaging. Customers will likely have access to sterilized goods and packaging as a result of the outbreak.

    Additionally, SCHOTT and West Pharmaceuticals Services signed a collaboration agreement in November 2019 to make sterile-packed, simple, easy-to-use injectable drug delivery systems available to the public. Thus, it is anticipated that this aspect will accelerate Injectable drug delivery market revenue globally. 

    There is a high potential for infection and dosage and handling mistakes to occur when using the traditional vial and syringe method of administering drugs. On the other hand, this may be minimized by switching to pre-filled syringes or reusable glass syringes, both of which are a safe and highly effective form of medication administration to the body. Increases in patient education and interest in less-intrusive injection methods are fueling the market's growth throughout the world.

    The market for injectable drug administration is growing for a number of reasons, including the advent of low-cost devices that are efficient, accurate, and easy to use. Product sales are expected to rise, contributing to the market's expansion throughout the forecast period, and new developments in healthcare infrastructure and novel approaches to medicine administration are expected to fuel the market's expansion. Because of this, the market's CAGR is rising.

    June 2023: Vertiva, an On-Body Delivery System (OBDS) designed to be suitable for a wide range of subcutaneous therapies, was introduced in June 2023 by Stevanato Group, S.p.A., a global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries. The innovative design of Vertiva includes a disposable pod that comes with a pre-filled and pre-loaded 3mL ISO cartridge, as well as a controller that may be used several times. A unique magnetically connected driving mechanism facilitates communication between these two components.

    The device is flexible enough to allow for the delivery of both small-molecule medicines and biologics.

    The evolution of injectable drug delivery systems is poised to enhance patient compliance and therapeutic efficacy, reflecting a growing trend towards personalized medicine and advanced biopharmaceuticals.

    U.S. Food and Drug Administration (FDA)

    Injectable Drug Delivery Devices Market Drivers

    Rising Demand for Biologics

    The Global Global Injectable Drug Delivery Market Industry is experiencing a surge in demand for biologics, which are increasingly recognized for their efficacy in treating chronic diseases. Biologics, including monoclonal antibodies and vaccines, require precise delivery methods, thus driving the growth of injectable drug delivery systems. The market is projected to reach 124.7 USD Billion in 2024, reflecting a growing preference for these advanced therapies. As healthcare providers and patients seek more effective treatment options, the need for innovative delivery mechanisms becomes paramount, further propelling the market forward.

    Market Segment Insights

    Injectable Drug Delivery Device Insights

    The market segments of injectable drug delivery, based on devices, includes conventional injection devices, and self-injection devices. The self-injection devices segment held the majority share in 2022 in the Injectable drug delivery market revenue. The market's fastest-growing sector comprises the items that makeup self-injection devices. The employment of these tools makes it easier to manage and control numerous illnesses on a fundamental level. Needles-free injectors allow for the painless delivery of pharmaceutical medications, making this market segment one of the most lucrative.

    Injectable Drug Delivery Therapeutics Application Insights

    The Injectable drug delivery market segmentation, based on therapeutics application, includes autoimmune diseases, hormonal disorders and cancer. The hormonal disorders and cancer segment dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. Due to the rising number of cancer cases worldwide and the increased amount of research being done to identify treatments for various types of cancer, the hormonal disorders and cancer segment contributed significantly to the worldwide injectable drug delivery market's revenue.

    Prostate cancer, breast cancer, rectal cancer, lung and bronchial cancer, non-Hodgkin lymphoma, and other malignancies are among the most prevalent. More than 2.3 million women will receive a breast cancer diagnosis in 2020.

    Figure 1: Injectable Drug Delivery Market, by Therapeutics Application, 2022 & 2030 (USD Billion)

     

    Injectable Drug Delivery Market, by Therapeutics Application, 2022 & 2030

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Injectable Drug Delivery Usage Pattern Insights

    The injectable drug delivery market data, based on usage pattern, includes curative pattern, and immunization. The immunization segment dominated the market revenue of injectable drug delivery in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. The outbreak of a pandemic has greatly increased the demand for country-wide immunization programs and is expected to continue to grow attributing to the prevalence of infectious diseases.

    Injectable Drug Delivery Site of Delivery Insights

    The injectable drug delivery industry, based on usage site of delivery, includes intramuscular, subcutaneous, intradermal. The intramuscular segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. This is due to the fact that most common injectable drugs are delivered through intramuscular shots such as upper arm, thigh and buttocks.

    Regional Insights

    By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Injectable drug delivery market accounted for USD 8.01 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. The rise in biologics sales and the rise in demand for self-injection devices are factors in the prevalence of chronic diseases.

    With the increasing cases of chronic diseases, the rise in disposable income, the rising concern for comfort and safety, and the rising number of partnerships in this market, this sector is expected to experience the largest growth. New product development, partnerships, partnerships, expansions, mergers, and acquisitions are the main strategies used by the organisations in the market.

    Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 3: INJECTABLE DRUG DELIVERY MARKET SHARE BY REGION 2022 (%)INJECTABLE DRUG DELIVERY MARKET SHARE BY REGION 2022

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Europe Injectable drug delivery market accounts for the second-largest market share. This region now dominates the market for insulin pens in Europe as a result of increasing research and development in this area. The two German businesses, Emperra GmbH E-Health Technologies and Pendiq Intelligent Diabetes Care, respectively, developed and commercialized the insulin pens ESYSTA and Pendiq. Moreover, UK market of Injectable drug delivery held the largest market share, and the Germany market of Injectable drug delivery was the fastest-growing market in the region.

    Asia Pacific Injectable drug delivery Market is expected to grow at the fastest CAGR from 2022 to 2030. It is Since more people are becoming aware of these delivery methods, there are more patients, and ready-to-use injectables are replacing traditional drug administration injectables. Further, the China market of Injectable drug delivery held the largest market share, and the India market of Injectable drug delivery was the fastest-growing market in the region.

    Key Players and Competitive Insights

    Major market players are spending a lot of money on R&D to increase their product lines, which will help the market of Injectable drug delivery grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, mergers and acquisitions, contractual agreements, increased investments, and collaboration with other organizations. Competitors in the Injectable drug delivery industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

    One of the primary business strategies adopted by manufacturers in the Injectable drug delivery industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, Injectable drug delivery industry has provided medicine with some of the most significant benefits. The Injectable drug delivery market major player such as Eisai Co. Ltd, Antares Pharma, AstraZeneca, Becton, Dickinson and Company, Eli Lilly and Company.

    With its corporate headquarters in Düsseldorf, Gerresheimer AG is a German manufacturer of packaging materials for medication and drug delivery systems manufactured of special-purpose glass and plastics. The corporation operates production facilities in Asia, the Americas, and Europe. Gerresheimer increased the scope of its collaboration with Taisei Medical Co. Ltd. in 2016 to promote its ClearJect syringes and offer technical support to customers. Additionally, the business intends to expand its line of COP syringes in collaboration with Taisei Medical by producing Gx RTF ClearJect brand syringes that combine ClearJect and its glass RTF (ready-to-fill) idea.

    This partnership is intended to assist the company in expanding both its clientele and product line in the syringe needles sector.

    An American international healthcare corporation, Baxter International Inc., has its corporate headquarters in Deerfield, Illinois. The company's main areas of concentration include chronic and acute medical disorders, including kidney illness. The leading manufacturer of active pharmaceutical ingredients, ScinoPharm Taiwan, Ltd., and Baxter International Inc. partnered strategically in February 2017. (API). Five injectable medications will need to be developed, produced, and made available for sale as part of this collaboration. 

    Key Companies in the Injectable Drug Delivery Devices Market market include

    Industry Developments

    • Q2 2024: Becton Dickinson launches new pre-filled syringe platform for biologics Becton Dickinson announced the launch of a new pre-filled syringe platform designed specifically for biologic drugs, aiming to improve drug stability and patient safety.
    • Q2 2024: West Pharmaceutical Services Announces Opening of New Manufacturing Facility in Singapore West Pharmaceutical Services opened a new manufacturing facility in Singapore to expand its production capacity for injectable drug delivery devices, targeting growth in the Asia-Pacific region.
    • Q3 2024: Ypsomed and Novo Nordisk enter partnership to develop next-generation autoinjectors Ypsomed and Novo Nordisk announced a partnership to co-develop next-generation autoinjectors for self-administration of biologic therapies.
    • Q3 2024: Stevanato Group receives FDA clearance for Alba® Connect smart injector Stevanato Group received FDA clearance for its Alba® Connect smart injector, a connected device designed to improve adherence and monitoring for injectable therapies.
    • Q4 2024: Phillips-Medisize secures contract to supply wearable injectors for major US pharma company Phillips-Medisize announced it has secured a contract to supply wearable injectors to a major US pharmaceutical company for a new biologic drug launch.
    • Q4 2024: SHL Medical raises $150 million in private funding round to expand autoinjector production SHL Medical completed a $150 million private funding round to expand its autoinjector manufacturing capacity and accelerate development of new delivery platforms.
    • Q1 2025: Gerresheimer acquires Sensile Medical to strengthen digital drug delivery portfolio Gerresheimer announced the acquisition of Sensile Medical, enhancing its portfolio with digital and connected drug delivery devices for injectable therapies.
    • Q1 2025: Bespak by Recipharm receives CE mark for new pen injector platform Bespak by Recipharm received CE mark approval for its new pen injector platform, enabling commercial launch in European markets.
    • Q2 2025: Owen Mumford appoints new CEO to drive global expansion of injectable device business Owen Mumford announced the appointment of a new CEO, tasked with accelerating global expansion and innovation in its injectable drug delivery device segment.
    • Q2 2025: Nemera opens new R&D center in France for advanced injectable device development Nemera opened a new research and development center in France focused on the design and development of advanced injectable drug delivery devices.
    • Q2 2025: Vetter Pharma secures multi-year contract with European biotech for fill-finish of injectable biologics Vetter Pharma announced a multi-year contract with a European biotech company to provide fill-finish services for injectable biologic products.
    • Q3 2025: Credence MedSystems closes $40 million Series C funding to accelerate commercialization of Companion® Syringe System Credence MedSystems closed a $40 million Series C funding round to support the commercialization and global rollout of its Companion® Syringe System for injectable drugs.

    Future Outlook

    Injectable Drug Delivery Devices Market Future Outlook

    The Global Injectable Drug Delivery Market is projected to grow at a 7.72% CAGR from 2024 to 2035, driven by technological advancements, increasing chronic diseases, and demand for self-administration devices.

    New opportunities lie in:

    • Develop smart injectors with integrated digital health solutions for better patient adherence.
    • Expand product lines to include biosimilars and monoclonal antibodies for diverse therapeutic areas.
    • Invest in partnerships with telehealth platforms to enhance remote patient monitoring and support.

    By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs and technological innovations.

    Market Segmentation

    Injectable drug delivery Regional Outlook (USD Billion, 2019-2030)

    North America
    • US
    • Canada

    Injectable Drug Delivery Devices, Devices Outlook (USD Billion, 2019-2030)

    • Conventional Injection Devices
    • Self-Injection Devices

    Injectable Drug Delivery Devices Usage Pattern Outlook (USD Billion, 2019-2030)

    • Curative pattern
    • Immunization

    Injectable Drug Delivery Devices Site of Delivery Outlook (USD Billion, 2019-2030)

    • Intramuscular
    • Subcutaneous
    • Intra Dermal

    Injectable Drug Delivery Devices Therapeutic Application Outlook (USD Billion, 2019-2030)

    •  Autoimmune Diseases
    • Hormonal Disorders and Cancer

    Report Scope

    Attribute/Metric Details
    Market Size 2023 USD 114.44 Billion
    Market Size 2024 USD 124.69 Billion
    Market Size 2032 USD 229.21 Billion
    Compound Annual Growth Rate (CAGR) 7.21% (2024-2032)
    Base Year 2023
    Market Forecast Period 2024-2032
    Historical Data 2019 - 2022
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Devices, Therapeutic Application, Site of Delivery and Region
    Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
    Countries Covered The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Eisai Co. Ltd, Antares Pharma, AstraZeneca, Becton, Dickinson and Company, Eli Lilly and Company.
    Key Market Opportunities Growing awareness of vaccination in third-world countries
    Key Market Dynamics Rapid increase in demand of medical equipment.

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    How much is the Injectable Drug Delivery Devices Market worth in the future?

    Market Research Future predicts that Global Injectable Drug Delivery Devices Market is estimated to reach USD 229.21 Billion by 2032

    Who are the major players in Injectable Drug Delivery Devices Market?

    Eisai Co., Ltd, Antares Pharma, AstraZeneca, Becton, Dickinson and Company, Eli Lilly and Company, F. Hoffmann-La Roche AG

    At what CAGR is the Injectable Drug Delivery Devices Market projected to grow in the forecast period?

    Global Injectable Drug Delivery Devices Market is expected to register a CAGR of 7.21% during forecast period upto 2032

    What is the Major factor driving the Injectable Drug Delivery Devices Market?

    Major factor contributing to the growth of the global Injectable Drug Delivery Devices Market is adoption of self-injectable devices, Rising FDA approvals for the drug delivery devices, and others.

    Which region is anticipated to hold the highest market share in the Injectable Drug Delivery Devices Market?

    The Americas is anticipated to dominate the global Injectable Drug Delivery Devices Market. This region is expected to reach USD 229.21 Billion by 2032 with a CAGR of 7.21% from 2024 to 2032.

    Which site of delivery had the largest market share in the Injectable drug delivery market?

    The intramuscular had the largest share in the global market.

    1. Report Prologue
    2. Market Introduction
      1. Scope of Study
      2. Research Objective 20
      3. List of Assumptions 20
    3. Research
    4. Methodology
      1. Research Process 23
      2. Primary Research 24
      3. Secondary
    5. Research 25
      1. Market Size Estimation 26
    6. Market Dynamics
      1. Introduction
      2. Drivers 29
        1. Increasing Prevalence of Chronic Diseases 29
        2. Growing Adoption of Self-Injectable Devices 29
        3. Rising FDA Approvals
        4. Drivers Impact Analysis 30
      3. Restraints 30
        1. Risks
    7. of Cross-Contamination 30
      1. Increasing Cost of High-End Products 30
        1. Restraints Impact Analysis 31
      2. Opportunity 31
        1. Increasing
    8. Campaigns of Vaccination in Developing Economies of the Asia-Pacific Region 31
      1. Macroeconomic Indicators 31
      2. Market Trend 32
        1. Increasing
    9. Use of Auto-Injectors Against Allergies 32
    10. Market Factor Analysis
    11. Value Chain Analysis 34
      1. R&D and Designing 34
        1. Manufacturing
        2. Distribution & Sales 34
        3. Post-Sales Review 35
    12. Porter’s Five Forces Model 35
      1. Threat of New Entrants 35
    13. Bargaining Power of Suppliers 36
      1. Threat of Substitutes 36
    14. Bargaining Power of Buyers 36
      1. Intensity of Rivalry 36
      2. Investment
    15. Opportunities 36
      1. Pricing Analysis 37
      2. Demand & Supply: Gap
    16. Analysis 37
    17. Injectable Drug Delivery Devices Market, by Devices
    18. Introduction 39
      1. Conventional Injection Devices 40
      2. Self-Injection
    19. Devices 42
    20. Injectable Drug Delivery Devices Market, by Therapeutic Application
      1. Introduction 44
      2. Autoimmune Diseases 45
      3. Hormonal Disorders
      4. Cancer 45
    21. Injectable Drug Delivery Devices Market, by Usage Pattern
      1. Introduction 47
      2. Curative Pattern 48
      3. Immunization 48
    22. Injectable Drug Delivery Devices Market, by Site of Delivery
      1. Introduction
      2. Intramuscular 51
      3. Subcutaneous 51
      4. Intra Dermal 51
    23. Injectable Drug Delivery Devices Market, by Distribution Channel
    24. Introduction 53
      1. Hospital & Retail Pharmacies 54
      2. Online Platforms
    25. Injectable Drug Delivery Devices Market, by Facility of Use
    26. Introduction 56
      1. Hospitals and Clinics 57
      2. Home Care Settings
    27. Global Injectable Drug Delivery Devices Market, by Region
      1. Introduction
      2. Americas 60
    28. Injectable Drug Delivery Devices Market, by Devices
    29. Injectable Drug Delivery Devices Market, by Therapeutic Application
    30. Injectable
    31. Drug Delivery Devices Market, by Usage Pattern
    32. Injectable Drug Delivery Devices
    33. Market, by Site of Delivery
    34. Injectable Drug Delivery Devices Market, by Distribution
    35. Channel
    36. Injectable Drug Delivery Devices Market, by Facility of Use
    37. North America 63
    38. Injectable Drug Delivery Devices Market, by Devices
    39. Injectable
    40. Drug Delivery Devices Market, by Therapeutic Application
    41. Injectable Drug Delivery
    42. Devices Market, by Usage Pattern
    43. Injectable Drug Delivery Devices Market, by
    44. Site of Delivery
    45. Injectable Drug Delivery Devices Market, by Distribution Channel
    46. Injectable Drug Delivery Devices Market, by Facility of Use
      1. US 66
    47. Injectable Drug Delivery Devices Market, by Devices
    48. Injectable Drug Delivery
    49. Devices Market, by Therapeutic Application
    50. Injectable Drug Delivery Devices
    51. Market, by Usage Pattern
    52. Injectable Drug Delivery Devices Market, by Site of
    53. Delivery
    54. Injectable Drug Delivery Devices Market, by Distribution Channel
    55. Injectable Drug Delivery Devices Market, by Facility of Use
      1. Canada
    56. Injectable Drug Delivery Devices Market, by Devices
    57. Injectable Drug
    58. Delivery Devices Market, by Therapeutic Application
    59. Injectable Drug Delivery
    60. Devices Market, by Usage Pattern
    61. Injectable Drug Delivery Devices Market, by
    62. Site of Delivery
    63. Injectable Drug Delivery Devices Market, by Distribution Channel
    64. Injectable Drug Delivery Devices Market, by Facility of Use
      1. South
    65. America 71
    66. Injectable Drug Delivery Devices Market, by Devices
    67. Injectable
    68. Drug Delivery Devices Market, by Therapeutic Application
    69. Injectable Drug Delivery
    70. Devices Market, by Usage Pattern
    71. Injectable Drug Delivery Devices Market, by
    72. Site of Delivery
    73. Injectable Drug Delivery Devices Market, by Distribution Channel
    74. Injectable Drug Delivery Devices Market, by Facility of Use
      1. Europe 74
    75. Injectable Drug Delivery Devices Market, by Devices
    76. Injectable Drug Delivery
    77. Devices Market, by Therapeutic Application
    78. Injectable Drug Delivery Devices
    79. Market, by Usage Pattern
    80. Injectable Drug Delivery Devices Market, by Site of
    81. Delivery
    82. Injectable Drug Delivery Devices Market, by Distribution Channel
    83. Injectable Drug Delivery Devices Market, by Facility of Use
      1. Western
    84. Europe 77
    85. Injectable Drug Delivery Devices Market, by Devices
    86. Injectable
    87. Drug Delivery Devices Market, by Therapeutic Application
    88. Injectable Drug Delivery
    89. Devices Market, by Usage Pattern
    90. Injectable Drug Delivery Devices Market, by
    91. Site of Delivery
    92. Injectable Drug Delivery Devices Market, by Distribution Channel
    93. Injectable Drug Delivery Devices Market, by Facility of Use
      1. Germany
    94. Injectable Drug Delivery Devices Market, by Devices
    95. Injectable Drug
    96. Delivery Devices Market, by Therapeutic Application
    97. Injectable Drug Delivery
    98. Devices Market, by Usage Pattern
    99. Injectable Drug Delivery Devices Market, by
    100. Site of Delivery
    101. Injectable Drug Delivery Devices Market, by Distribution Channel
    102. Injectable Drug Delivery Devices Market, by Facility of Use
      1. UK 83
    103. Injectable Drug Delivery Devices Market, by Devices
    104. Injectable Drug Delivery
    105. Devices Market, by Therapeutic Application
    106. Injectable Drug Delivery Devices
    107. Market, by Usage Pattern
    108. Injectable Drug Delivery Devices Market, by Site of
    109. Delivery
    110. Injectable Drug Delivery Devices Market, by Distribution Channel
    111. Injectable Drug Delivery Devices Market, by Facility of Use
      1. France
    112. Injectable Drug Delivery Devices Market, by Devices
    113. Injectable Drug
    114. Delivery Devices Market, by Therapeutic Application
    115. Injectable Drug Delivery
    116. Devices Market, by Usage Pattern
    117. Injectable Drug Delivery Devices Market, by
    118. Site of Delivery
    119. Injectable Drug Delivery Devices Market, by Distribution Channel
    120. Injectable Drug Delivery Devices Market, by Facility of Use
      1. Italy
    121. Injectable Drug Delivery Devices Market, by Devices
    122. Injectable Drug
    123. Delivery Devices Market, by Therapeutic Application
    124. Injectable Drug Delivery
    125. Devices Market, by Usage Pattern
    126. Injectable Drug Delivery Devices Market, by
    127. Site of Delivery
    128. Injectable Drug Delivery Devices Market, by Distribution Channel
    129. Injectable Drug Delivery Devices Market, by Facility of Use
      1. Spain
    130. Injectable Drug Delivery Devices Market, by Devices
    131. Injectable Drug
    132. Delivery Devices Market, by Therapeutic Application
    133. Injectable Drug Delivery
    134. Devices Market, by Usage Pattern
    135. Injectable Drug Delivery Devices Market, by
    136. Site of Delivery
    137. Injectable Drug Delivery Devices Market, by Distribution Channel
    138. Injectable Drug Delivery Devices Market, by Facility of Use
      1. Rest
    139. of Western Europe 94
    140. Injectable Drug Delivery Devices Market, by Devices
    141. Injectable Drug Delivery Devices Market, by Therapeutic Application
    142. Injectable
    143. Drug Delivery Devices Market, by Usage Pattern
    144. Injectable Drug Delivery Devices
    145. Market, by Site of Delivery
    146. Injectable Drug Delivery Devices Market, by Distribution
    147. Channel
    148. Injectable Drug Delivery Devices Market, by Facility of Use
    149. Eastern Europe 97
    150. Injectable Drug Delivery Devices Market, by Devices
    151. Injectable
    152. Drug Delivery Devices Market, by Therapeutic Application
    153. Injectable Drug Delivery
    154. Devices Market, by Usage Pattern
    155. Injectable Drug Delivery Devices Market, by
    156. Site of Delivery
    157. Injectable Drug Delivery Devices Market, by Distribution Channel
    158. Injectable Drug Delivery Devices Market, by Facility of Use
      1. Asia-Pacific
    159. Injectable Drug Delivery Devices Market, by Devices
    160. Injectable Drug
    161. Delivery Devices Market, by Therapeutic Application
    162. Injectable Drug Delivery
    163. Devices Market, by Usage Pattern
    164. Injectable Drug Delivery Devices Market, by
    165. Site of Delivery
    166. Injectable Drug Delivery Devices Market, by Distribution Channel
    167. Injectable Drug Delivery Devices Market, by Facility of Use
      1. Japan
    168. Injectable Drug Delivery Devices Market, by Devices
    169. Injectable Drug
    170. Delivery Devices Market, by Therapeutic Application
    171. Injectable Drug Delivery
    172. Devices Market, by Usage Pattern
    173. Injectable Drug Delivery Devices Market, by
    174. Site of Delivery
    175. Injectable Drug Delivery Devices Market, by Distribution Channel
    176. Injectable Drug Delivery Devices Market, by Facility of Use
      1. China
    177. Injectable Drug Delivery Devices Market, by Devices
    178. Injectable Drug
    179. Delivery Devices Market, by Therapeutic Application
    180. Injectable Drug Delivery
    181. Devices Market, by Usage Pattern
    182. Injectable Drug Delivery Devices Market, by
    183. Site of Delivery
    184. Injectable Drug Delivery Devices Market, by Distribution Channel
    185. Injectable Drug Delivery Devices Market, by Facility of Use
      1. India
    186. Injectable Drug Delivery Devices Market, by Devices
    187. Injectable Drug
    188. Delivery Devices Market, by Therapeutic Application
    189. Injectable Drug Delivery
    190. Devices Market, by Usage Pattern
    191. Injectable Drug Delivery Devices Market, by
    192. Site of Delivery
    193. Injectable Drug Delivery Devices Market, by Distribution Channel
    194. Injectable Drug Delivery Devices Market, by Facility of Use
      1. South
    195. Korea 111
    196. Injectable Drug Delivery Devices Market, by Devices
    197. Injectable
    198. Drug Delivery Devices Market, by Therapeutic Application
    199. Injectable Drug Delivery
    200. Devices Market, by Usage Pattern
    201. Injectable Drug Delivery Devices Market, by
    202. Site of Delivery
    203. Injectable Drug Delivery Devices Market, by Distribution Channel
    204. Injectable Drug Delivery Devices Market, by Facility of Use
      1. Australia
    205. Injectable Drug Delivery Devices Market, by Devices
    206. Injectable Drug
    207. Delivery Devices Market, by Therapeutic Application
    208. Injectable Drug Delivery
    209. Devices Market, by Usage Pattern
    210. Injectable Drug Delivery Devices Market, by
    211. Site of Delivery
    212. Injectable Drug Delivery Devices Market, by Distribution Channel
    213. Injectable Drug Delivery Devices Market, by Facility of Use
      1. Rest of
    214. Asia-Pacific 117
    215. Injectable Drug Delivery Devices Market, by Devices
    216. Injectable
    217. Drug Delivery Devices Market, by Therapeutic Application
    218. Injectable Drug Delivery
    219. Devices Market, by Usage Pattern
    220. Injectable Drug Delivery Devices Market, by
    221. Site of Delivery
    222. Injectable Drug Delivery Devices Market, by Distribution Channel
    223. Injectable Drug Delivery Devices Market, by Facility of Use
      1. Middle East
    224. & Africa 120
    225. Injectable Drug Delivery Devices Market, by Devices
    226. Injectable
    227. Drug Delivery Devices Market, by Therapeutic Application
    228. Injectable Drug Delivery
    229. Devices Market, by Usage Pattern
    230. Injectable Drug Delivery Devices Market, by
    231. Site of Delivery
    232. Injectable Drug Delivery Devices Market, by Distribution Channel
    233. Injectable Drug Delivery Devices Market, by Facility of Use
      1. Middle
    234. East 123
    235. Injectable Drug Delivery Devices Market, by Devices
    236. Injectable
    237. Drug Delivery Devices Market, by Therapeutic Application
    238. Injectable Drug Delivery
    239. Devices Market, by Usage Pattern
    240. Injectable Drug Delivery Devices Market, by
    241. Site of Delivery
    242. Injectable Drug Delivery Devices Market, by Distribution Channel
    243. Injectable Drug Delivery Devices Market, by Facility of Use
      1. Africa
    244. Injectable Drug Delivery Devices Market, by Devices
    245. Injectable Drug
    246. Delivery Devices Market, by Therapeutic Application
    247. Injectable Drug Delivery
    248. Devices Market, by Usage Pattern
    249. Injectable Drug Delivery Devices Market, by
    250. Site of Delivery
    251. Injectable Drug Delivery Devices Market, by Distribution Channel
    252. Injectable Drug Delivery Devices Market, by Facility of Use
    253. Competitive Landscape
      1. Introduction 130
    254. Company Profile
      1. Eisai Co.,
    255. Ltd. 132
      1. Company Overview 132
        1. Financial Overview 132
        2. Products Offered 133
        3. Key Developments 133
        4. SWOT
    256. Analysis 133
      1. Key Strategies 133
      2. Antares Pharma 134
    257. Company Overview 134
      1. Financial Overview 134
        1. Products Offered
        2. Key Developments 135
        3. SWOT Analysis 135
        4. Key
    258. Strategies 135
      1. AstraZeneca 136
        1. Company Overview 136
    259. Financial Overview 136
      1. Pipeline Products 137
        1. Key Developments
        2. SWOT Analysis 137
        3. Key Strategies 137
      2. Becton,
    260. Dickinson and Company 138
      1. Company Overview 138
        1. Financial
    261. Overview 138
      1. Products Offered 139
        1. Key Developments 139
        2. SWOT Analysis 140
        3. Key Strategies 140
      2. Eli Lilly and
    262. Company 141
      1. Company Overview 141
        1. Financial Overview 141
        2. Products Offered 142
        3. Key Developments 142
        4. SWOT
    263. Analysis 142
      1. Key Strategies 142
      2. F. Hoffmann-La Roche AG 143
        1. Company Overview 143
        2. Financial Overview 143
        3. Products
    264. Offered 144
      1. Key Developments 144
        1. SWOT Analysis 144
    265. Key Strategies 144
      1. Johnson & Johnson Services Inc. 145
    266. Company Overview 145
      1. Financial Overview 145
        1. Products Offered
        2. Key Developments 146
        3. SWOT Analysis 146
        4. Key
    267. Strategies 146
      1. Mylan N.V. 147
        1. Company Overview 147
    268. Financial Overview 147
      1. Products Offered 148
        1. Key Developments
        2. SWOT Analysis 148
        3. Key Strategies 148
      2. Novartis
    269. AG 149
      1. Company Overview 149
        1. Financial Overview 149
    270. Products Offered 150
      1. Key Developments 150
        1. SWOT Analysis
        2. Key Strategies 150
      2. Novo Nordisk 151
        1. Company
    271. Overview 151
      1. Financial Overview 151
        1. Products Offered 152
        2. Key Developments 152
        3. SWOT Analysis 152
        4. Key Strategies
      2. Pfizer Inc. 153
        1. Company Overview 153
        2. Financial
    272. Overview 153
      1. Products Offered 154
        1. Key Developments 154
        2. SWOT Analysis 154
        3. Key Strategies 154
      2. Sanofi 155
        1. Company Overview 155
        2. Financial Overview 155
    273. Products Offered 156
      1. Key Developments 156
        1. SWOT Analysis
        2. Key Strategies 156
      2. Teva Pharmaceutical Industries Ltd
        1. Company Overview 157
        2. Financial Overview 157
    274. Products Offered 158
      1. Key Developments 158
        1. SWOT Analysis
        2. Key Strategies 158
      2. Inovio Pharmaceuticals Inc. 159
        1. Company Overview 159
        2. Financial Overview 159
    275. Products Offered 160
      1. Key Developments 160
        1. SWOT Analysis
        2. Key Strategies 160
    276. Appendix
      1. Discussion Blue Print
    277. List of Tables
    278. INTERVIEWS 24
    279. –2027 (USD MILLION) 39
    280. MARKET, FOR CONVENTIONAL INJECTION DEVICES BY REGION 2020–2027 (USD MILLION)
    281. (USD MILLION) 40
    282. –2027 (USD MILLION) 41
    283. MARKET BY USABILITY 2020–2027 (USD MILLION) 41
    284. DRUG DELIVERY DEVICES MARKET, FOR SELF-INJECTION DEVICES BY REGION 2020–2027
    285. (USD MILLION) 42
    286. –2027 (USD MILLION) 42
    287. MARKET, BY THERAPEUTIC APPLICATION 2020–2027 (USD MILLION) 44
    288. GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR AUTOIMMUNE DISEASES BY REGION
    289. –2027 (USD MILLION) 45
    290. MARKET, FOR HORMONAL DISORDERS BY REGION 2020–2027 (USD MILLION) 45
    291. GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR CANCER BY REGION 2020–2027
    292. (USD MILLION) 45
    293. USAGE PATTERN 2020–2027 (USD MILLION) 47
    294. DELIVERY DEVICES MARKET, FOR CURATIVE PATTERN BY REGION 2020–2027 (USD MILLION)
    295. BY REGION 2020–2027 (USD MILLION) 48
    296. DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 50
    297. REGION 2020–2027 (USD MILLION) 51
    298. DEVICES MARKET, FOR SUBCUTANEOUS BY REGION 2020–2027 (USD MILLION) 51
    299. GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR INTRA DERMAL BY REGION 2020–2027
    300. (USD MILLION) 51
    301. DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 53
    302. DRUG DELIVERY DEVICES MARKET, FOR HOSPITAL & RETAIL PHARMACIES BY REGION 2020–2027
    303. (USD MILLION) 54
    304. ONLINE PLATFORMS BY REGION 2020–2027 (USD MILLION) 54
    305. INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD
    306. MILLION) 56
    307. AND CLINICS BY REGION 2020–2027 (USD MILLION) 57
    308. DRUG DELIVERY DEVICES MARKET, FOR HOME CARE SETTINGS BY REGION 2020–2027 (USD
    309. MILLION) 57
    310. –2027 (USD MILLION) 59
    311. DEVICES MARKET, BY REGION 2020–2027 (USD MILLION) 60
    312. INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION)
    313. (USD MILLION) 61
    314. MATERIAL 2020–2027 (USD MILLION) 61
    315. DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 61
    316. CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION)
    317. –2027 (USD MILLION) 62
    318. DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION) 62
    319. AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION
    320. & 2027 (USD MILLION) 62
    321. DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 62
    322. AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027
    323. (USD MILLION) 63
    324. BY DEVICES 2020–2027 (USD MILLION) 63
    325. DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 63
    326. AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION)
    327. –2027 (USD MILLION) 64
    328. DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 64
    329. AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027
    330. (USD MILLION) 64
    331. BY SITE OF DELIVERY 2020–2027 (USD MILLION) 64
    332. INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027
    333. (USD MILLION) 65
    334. BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 65
    335. INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD
    336. MILLION) 65
    337. –2027 (USD MILLION) 66
    338. BY PRODUCT TYPE 2020–2027 (USD MILLION) 66
    339. DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION) 66
    340. INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 66
    341. US CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION)
    342. (USD MILLION) 67
    343. OF DELIVERY 2020–2027 (USD MILLION) 67
    344. DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 67
    345. US INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027
    346. (USD MILLION) 68
    347. OF USE 2020–2027 (USD MILLION) 68
    348. DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 68
    349. SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 68
    350. (USD MILLION) 69
    351. –2027 (USD MILLION) 69
    352. MARKET BY USABILITY 2020–2027 (USD MILLION) 69
    353. DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 69
    354. (USD MILLION) 70
    355. THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 70
    356. DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION)
    357. USE 2020–2027 (USD MILLION) 71
    358. DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 71
    359. SOUTH AMERICA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD
    360. MILLION) 71
    361. MATERIAL 2020–2027 (USD MILLION) 71
    362. INJECTION DEVICES MARKET BY PRODUCT 2020–2027 (USD MILLION) 72
    363. SOUTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2020–2027
    364. (USD MILLION) 72
    365. BY USAGE PATTERN 2020–2027 (USD MILLION) 72
    366. DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027 (USD MILLION)
    367. APPLICATION 2020 & 2027 (USD MILLION) 73
    368. DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION)
    369. OF USE 2020–2027 (USD MILLION) 73
    370. DEVICES MARKET, BY REGION 2020–2027 (USD MILLION) 74
    371. INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION)
    372. (USD MILLION) 75
    373. –2027 (USD MILLION) 75
    374. MARKET BY PRODUCT 2020–2027 (USD MILLION) 75
    375. INJECTION DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 75
    376. EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027
    377. (USD MILLION) 76
    378. SITE OF DELIVERY 2020–2027 (USD MILLION) 76
    379. DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION)
    380. CHANNEL 2020–2027 (USD MILLION) 76
    381. DEVICES MARKET, BY FACILITY OF USE 2020–2027 (USD MILLION) 77
    382. EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY COUNTRY 2020–2027 (USD
    383. MILLION) 77
    384. BY DEVICES 2020–2027 (USD MILLION) 77
    385. DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 78
    386. EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION)
    387. –2027 (USD MILLION) 78
    388. DEVICES MARKET BY USABILITY 2020–2027 (USD MILLION) 78
    389. EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027
    390. (USD MILLION) 79
    391. BY SITE OF DELIVERY 2020–2027 (USD MILLION) 79
    392. INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027
    393. (USD MILLION) 79
    394. BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 80
    395. EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027
    396. (USD MILLION) 80
    397. BY DEVICES 2020–2027 (USD MILLION) 80
    398. DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 80
    399. CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION)
    400. (USD MILLION) 81
    401. USABILITY 2020–2027 (USD MILLION) 81
    402. DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 81
    403. GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027
    404. (USD MILLION) 82
    405. BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 82
    406. INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027
    407. (USD MILLION) 82
    408. BY FACILITY OF USE 2020–2027 (USD MILLION) 83
    409. DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 83
    410. UK SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION)
    411. (USD MILLION) 83
    412. –2027 (USD MILLION) 84
    413. MARKET BY USABILITY 2020–2027 (USD MILLION) 84
    414. DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 84
    415. (USD MILLION) 84
    416. APPLICATION 2020 & 2027 (USD MILLION) 85
    417. DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 85
    418. UK INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2020–2027
    419. (USD MILLION) 85
    420. BY DEVICES 2020–2027 (USD MILLION) 86
    421. DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 86
    422. CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2020–2027 (USD MILLION)
    423. (USD MILLION) 86
    424. USABILITY 2020–2027 (USD MILLION) 87
    425. DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 87
    426. FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2020–2027
    427. (USD MILLION) 87
    428. BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 87
    429. INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027
    430. (USD MILLION) 88
    431. BY FACILITY OF USE 2020–2027 (USD MILLION) 88
    432. DRUG DELIVERY DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 88
    433. ITALY SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION)
    434. (USD MILLION) 89
    435. –2027 (USD MILLION) 89
    436. MARKET BY USABILITY 2020–2027 (USD MILLION) 89
    437. DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 89
    438. (USD MILLION) 90
    439. THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 90
    440. DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION)
    441. USE 2020–2027 (USD MILLION) 91
    442. DEVICES MARKET, BY DEVICES 2020–2027 (USD MILLION) 91
    443. SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 91
    444. (USD MILLION) 91
    445. –2027 (USD MILLION) 92
    446. MARKET BY USABILITY 2020–2027 (USD MILLION) 92
    447. DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2020–2027 (USD MILLION) 92
    448. (USD MILLION) 92
    449. THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 93
    450. DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION)

    Market Segmentation

    Injectable Drug Delivery Devices Devices Outlook (USD Billion, 2019-2030)

    • Conventional Injection Devices
    • Self-Injection Devices

    Injectable Drug Delivery Devices Therapeutic Application Outlook (USD Billion, 2019-2030)

    • Autoimmune Diseases
    • Hormonal Disorders and Cancer

    Injectable Drug Delivery Devices Usage Pattern Outlook (USD Billion, 2019-2030)

    • Curative pattern
    • Immunization

    Injectable Drug Delivery Devices Site of Delivery Outlook (USD Billion, 2019-2030)

    • Intramuscular
    • Subcutaneous
    • Intra Dermal

    Injectable Drug Delivery Devices Regional Outlook (USD Billion, 2019-2030)

    • North America Outlook (USD Billion, 2019-2030)

      • North America Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • North America Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • North America Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • North America Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal
      • US Outlook (USD Billion, 2019-2030)

      • US Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • US Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • US Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • US Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal
      • CANADA Outlook (USD Billion, 2019-2030)

      • CANADA Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • CANADA Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • CANADA Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • CANADA Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal
    • Europe Outlook (USD Billion, 2019-2030)

      • Europe Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • Europe Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • Europe Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • Europe Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal
      • Germany Outlook (USD Billion, 2019-2030)

      • Germany Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • Germany Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • Germany Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • Germany Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal
      • France Outlook (USD Billion, 2019-2030)

      • France Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • France Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • France Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • France Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal
      • UK Outlook (USD Billion, 2019-2030)

      • UK Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • UK Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • UK Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • UK Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal
      • ITALY Outlook (USD Billion, 2019-2030)

      • ITALY Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • ITALY Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • ITALY Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • ITALY Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal

     

      • SPAIN Outlook (USD Billion, 2019-2030)

      • Spain Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • Spain Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • Spain Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • Spain Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal
      • Rest Of Europe Outlook (USD Billion, 2019-2030)

      • Rest Of Europe Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • REST OF EUROPE Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • REST OF EUROPE Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • REST OF EUROPE Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal
    • Asia-Pacific Outlook (USD Billion, 2019-2030)

      • Asia-Pacific Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • Asia-Pacific Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • Asia-Pacific Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • Asia-Pacific Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal
      • China Outlook (USD Billion, 2019-2030)

      • China Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • China Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • China Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • China Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal
      • Japan Outlook (USD Billion, 2019-2030)

      • Japan Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • Japan Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • Japan Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • Japan Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal
      • India Outlook (USD Billion, 2019-2030)

      • India Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • India Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • India Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • India Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal
      • Australia Outlook (USD Billion, 2019-2030)

      • Australia Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • Australia Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • Australia Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • Australia Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal
      • Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)

      • Rest of Asia-Pacific Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • Rest of Asia-Pacific Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • Rest of Asia-Pacific Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • Rest of Asia-Pacific Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal
    • Rest of the World Outlook (USD Billion, 2019-2030)

      • Rest of the World Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • Rest of the World Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • Rest of the World Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • Rest of the World Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal

    Middle East Outlook (USD Billion, 2019-2030)

      • Middle East Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • Middle East Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • Middle East Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • Middle East Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal
      • Africa Outlook (USD Billion, 2019-2030)

      • Africa Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • Africa Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • Africa Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • Africa Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal
      • Latin America Outlook (USD Billion, 2019-2030)

      • Latin America Injectable Drug Delivery Devices by Devices
        • Conventional Injection Devices
        • Self-Injection Devices
      • Latin America Injectable Drug Delivery Devices by Therapeutic Application
        • Autoimmune Diseases
        • Hormonal Disorders and Cancer
      • Latin America Injectable Drug Delivery Devices by Usage Pattern
        • Curative pattern
        • Immunization
      • Latin America Injectable Drug Delivery Devices by Site of Delivery
        • Intramuscular
        • Subcutaneous
        • Intra Dermal
    Injectable Drug Delivery Devices Market Research Report - Global Forecast To 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials